Globus Medical (GMED) PT Lowered to $80 at Stifel on 'Modest Upside Potential'
Tweet Send to a Friend
Stifel analyst Thomas M. Stephan lowered the price target on Globus Medical (NYSE: GMED) to $80.00 (from $95.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
